Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
| Status: | Archived |
|---|---|
| Conditions: | High Cholesterol, Diabetes |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | November 2010 |
| End Date: | October 2011 |
A 12-Week, Double-Blind, Randomized, Placebo-Controlled Study to Assess the LDL Cholesterol Lowering and Anti-Hyperglycemic Efficacy of Welchol® (Colesevelam) in Subjects With Impaired Fasting Glucose Who Are Taking Niaspan® (Niacin) for Dyslipidemia
The present study will assess the low-density lipoprotein cholesterol (LDL-C) lowering
effect of colesevelam as an adjunct to niacin for the improvement of lipids and glycemic
control in dyslipidemic subjects with impaired fasting glucose.
We found this trial at
4
sites
1351 Kimberly Rd
Bettendorf, Iowa 52722
Bettendorf, Iowa 52722
(563) 355-7733
Hematology Oncology Associates of the Quad Cities
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials